February 19, 2025

FDA Approves Amneal’s Lenalidomide; Mesalamine 800 mg Launched

Mesalamine 800 mg delayed-release tablets have been launched, and FDA approval has been granted for lenalidomide, with plans for entry into the U.S. generic market in 2026.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

January 31, 2025

Can Your Eyes Predict Parkinson’s? Retinal Changes May Offer Early Clues

Longitudinal study highlights how subtle retinal alterations could serve as early indicators of Parkinson’s disease progression.

Conexiant

November 07, 2024

AI in Neuropathology: How Language Models Are Transforming Brain Tumor Diagnosis

New research explores how integrating AI with clinical guidelines can enhance diagnostic precision for complex brain tumors.

Conexiant

November 18, 2024

The Adaptive Immune System's Role in Gut Health and IBD

Researchers identified segment-specific effects of immune cells on intestinal contractions, providing new angles for managing inflammatory bowel disease.

Conexiant

October 15, 2024

Novel Anti-Acetylated Tau Antibodies Offer New Insights and Potential Therapies for Alzheimer's Disease

With the development of monoclonal antibodies against acetylated tau, researchers unlock new possibilities for Alzheimer's diagnostics and treatment.

Conexiant

December 20, 2024

Riluzole Shows Promise in Reversing Cognitive Decline from Radiation Therapy

Boosting brain-derived neurotrophic factor (BDNF) with riluzole may mitigate cognitive dysfunction from radiation therapy.

Conexiant

September 26, 2024

Breast Cancer Diagnosis: 55% Gain in Efficiency With AI-Assisted Pathology

AI technology aids pathologists in improving diagnostic speed and accuracy in the challenging task of detecting breast cancer metastases in lymph nodes.

Conexiant

January 06, 2025

Female Vulnerability to Alzheimer’s Linked to Unique Genetic Pathways

Neuropathology-based genetic study links disrupted lipid metabolism and immune dysfunction to Alzheimer’s.

Conexiant